Cancer Can’t Wait: Best of ASCO 2025 Bengaluru Brings Global Breakthroughs to Indian Cancer Care
Bengaluru, August 23, 2025: Cutting-edge cancer research and innovations were brought closer to Indian patients today as the Best of ASCO 2025 Annual Meeting opened in Bengaluru. The two-day conference, officially licensed by the American Society of Clinical Oncology (ASCO) and hosted by the Global Healthcare Academy (GHA), has gathered more than 500 oncologists, researchers, and healthcare professionals to explore the latest advances in prevention, early detection, and treatment of cancer.
As India’s first Med Ed-tech platform dedicated to Continuing Medical Education (CME), GHA is working to connect global scientific progress with local healthcare needs. Through events like Best of ASCO, the academy ensures Indian doctors, students, and researchers gain timely access to breakthroughs that can transform patient care.
Awareness and Early Detection Take Center Stage
While discussions showcased innovations such as immunotherapy, targeted drugs, and CAR-T cell therapy, experts repeatedly emphasized that awareness, preventive choices, and early detection remain as powerful as advanced treatments.
In India, late-stage diagnosis continues to impact survival rates. Experts identified pollution, pesticide use, tobacco consumption, unhealthy diets, and limited awareness of family history as key drivers of the country’s cancer burden.
Dr. B. S. Ajaikumar, Chairman, HealthCare Global Enterprises (HCG) emphasized, “Cancer care in India must expand beyond treatment to include awareness, prevention, screening, and timely action. Early detection not only saves lives but also makes care more effective and affordable.”
Dr. Rakesh Jalali, Medical Director, Apollo Proton Cancer Centre, Chennai said, “From proton therapy to genetic testing, science has given us powerful tools. But they matter only if combined with early diagnosis and proactive awareness. The first and strongest treatment is awareness.”
Power of Genetic Counselling
Oncologists urged families with multiple cancer cases, rare cancers, or early-age diagnoses to consider genetic counselling and testing. Experts stressed that genetic risk awareness is about empowerment, not fear, enabling families to act before cancers progress to advanced stages.
Apollo Hospitals’ Oncology Lead Consultant:
“Far too many patients in India present with advanced cancers that could have been caught earlier. Family history, genetic testing, and lifestyle changes are as vital as chemotherapy or surgery.”
A Shared Social Responsibility
Dr. Arvind Krishnamurthy, Professor & Head, Surgical Oncology, and Honorary Secretary, Indian Society of Oncology stressed, “Cancer is not just a medical condition but a societal challenge. From rural areas to urban centres, the message is simple—act early, get screened, and don’t ignore symptoms. Knowledge is the foundation of saving lives.”
Doctors highlighted that everyday steps—balanced diets, regular exercise, avoiding tobacco and processed foods, and reducing chemical exposure—remain effective defences against long-term cancer risk.
GHA’s Mission in Cancer Education
Anitha Niranjan, Managing Director, Global Healthcare Academy said, “Hosting Best of ASCO 2025 reflects our mission to close the gap between global research and Indian practice. We are committed to developing advanced CME programs in genetic testing, immunotherapy, and precision oncology so that healthcare professionals can stay future-ready.”
Highlights from Best of ASCO 2025 Bengaluru
Advances in genetic testing and cancer screening improving survival rates.
Breakthrough treatments like immunotherapy and CAR-T cell therapy offering hope in advanced cancers.
Tackling India-specific challenges such as late diagnosis and limited rural access.
City Today News 9341997936
City Today News 